FOLH1 and Familial prostate cancer: These findings suggest that PSMA PET/CT is not only pivotal in the initial diagnosis and staging but also plays a significant role in the ongoing assessment and monitoring of prostate cancer, facilitating timely and informed therapeutic interventions.